Foster James Alexander Cunliffe - 31 Mar 2025 SCHEDULE 13G/A Report for Virax Biolabs Group Limited Ordinary Shares (VRAX)

Filing Manager: Foster James Alexander Cunliffe
Reporting Manager: James Foster
Security: Virax Biolabs Group Limited Ordinary Shares
Symbol: VRAX
Shares outstanding: 4,440,602 shares
Disclosed Ownership: 368,570 shares
Ownership: 8.3%
Form type: SCHEDULE 13G/A
Filing time: 29 Oct 2025, 17:16:14 UTC
Date of event: 31 Mar 2025
Previous filing: 29 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
James Foster	8.3%	368,570	368,570	0	James Foster	Chief Executive Officer